Amanda Feilding
Executive Director and Founder
Data updated
Research Footprint
Amanda Feilding appears in 50 tracked papers (2010–2025), most studied alongside LSD, Psilocybin and Ayahuasca, across Healthy Volunteers, Neuroimaging & Brain Measures and Depressive Disorders.
Most-cited paper: Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (1520 citations).
Frequent co-authors: Robin Carhart-Harris, David Nutt and Mendel Kaelen.
Background & Research
Amanda Feilding (1943–2025) was a British drug policy reformer and the founder of the Beckley Foundation. Often described as the 'hidden hand' behind the psychedelic renaissance, she dedicated her life to the study of consciousness and the scientific validation of psychedelics. Through the Beckley Foundation, she collaborated on many of the first modern human studies with LSD, psilocybin, and MDMA.
Key Impact
Innocative figure in psychedelic research and founder of the Beckley Foundation.
Collaboration Network
77 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Amanda Feilding is associated with.